Ibotta, Inc. (IBTA) Bundle
As investors weigh whether Ibotta, Inc. (IBTA) is a bargain or a risk, the snapshot is stark: the stock sits at $21.95 per share with a market cap near $558.8 million, yet the company reported full-year 2024 revenue of $367.3 million while suffering dramatic profitability hits-Q1 2025 net income plunged 94% year-over-year and adjusted EBITDA slid 35%-even as it holds a healthy cash and short-term investments balance of $223.3 million; juxtapose that with a 40.06% year-to-date stock decline, a 0% debt-to-equity ratio but a troubling interest coverage of -1.3, mixed quarterly revenue trends (Q1-Q3 2025 ranging from $84.6M to $83.3M with a Q3 16% drop attributed to lower-value channels), and an average one-year price target of $30.45 that paradoxically implies a 6.95% downside-read on for a line-by-line breakdown of revenue, margins, liquidity, valuation, risks, and growth levers that investors need to parse before deciding.
Ibotta, Inc. (IBTA) - Revenue Analysis
Stock snapshot: Ibotta, Inc. (IBTA) is an equity trading in the USA. Current price: 21.95 USD (change: +0.12 USD / +0.01% vs. previous close). Latest trade time: Wednesday, December 17, 16:15:00 PST.
- Primary revenue model: consumer rebates and advertising/partnership fees earned from CPG brands, retailers and ad networks.
- Revenue drivers: active users, average order value (AOV) of partner purchases, take-rate on cash-back + advertising yield per active user.
- Near-term pressure points: promotional economics (cash-back liability), marketing spend to acquire/retain users, and advertiser demand sensitivity to macro consumer trends.
| Metric | Most Recent | Notes / Implication |
|---|---|---|
| Share price (USD) | 21.95 | Snapshot as of 12/17, 16:15 PST |
| Intraday change | +0.12 (0.01%) | Low volatility at latest trade |
| Revenue model mix | Rebates vs. Ads (variable) | Ad monetization boosts margin vs. pure rebate revenue |
| Customer acquisition sensitivity | High | Marketing spend closely tied to short-term revenue growth |
| Key unit metrics to monitor | Active users, ARPU, take-rate, gross margin | Drive valuation via scale and monetization |
Revenue growth levers and scenario projections (illustrative):
- Base case (healthy ad demand): annual revenue CAGR ~18-25% driven by ARPU expansion and modest user growth.
- Upside (accelerating monetization): CAGR >30% if advertiser budgets shift more to performance and in-app commerce increases AOV.
- Downside (macro slowdown): single-digit growth or contraction if ad spend and consumer discretionary purchases decline.
Key financial/operational metrics investors should track quarter-to-quarter:
- Monthly active users (MAU) and quarterly active users (QAU)
- Average revenue per active user (ARPU)
- Gross margin on net receipts after cash-back payouts
- Marketing spend as % of revenue (CAC payback period)
- Retention/churn cohort economics and lifetime value (LTV)
Example sensitivity table (illustrative projections, not company disclosures):
| Scenario | Annual Revenue Growth | ARPU change | Marketing % of Revenue |
|---|---|---|---|
| Downside | 5% | -5% | 28% |
| Base | 20% | +8% | 18% |
| Upside | 35% | +18% | 12% |
Qualitative considerations that affect revenue realization:
- Platform breadth: growth in retailer & CPG partnerships expands addressable monetization opportunities.
- Product enhancements: conversion improvements (e.g., faster checkout, personalized offers) lift ARPU.
- Regulatory and privacy changes: ad targeting constraints can compress yield per user.
- Balance-sheet implications: deferred cash-back liabilities and timing differences between payout and revenue recognition.
For context on corporate orientation and strategic priorities, see: Mission Statement, Vision, & Core Values (2026) of Ibotta, Inc.
Ibotta, Inc. (IBTA) - Profitability Metrics
Ibotta's top-line trajectory through 2024-2025 shows mixed momentum, with full-year 2024 growth but several soft quarters in 2025 that pressure near-term profitability and operating leverage.- Full-year 2024 revenue: $367.3 million (up 15% vs. 2023).
- Q4 2024 revenue: $98.4 million (down 1% year-over-year).
- Q1 2025 revenue: $84.6 million (up 3% year-over-year).
- Q2 2025 revenue: $86.0 million (down 2% sequentially vs. year-ago comparison).
- Q3 2025 revenue: $83.3 million (down 16% year-over-year) - decline attributed to a shift toward lower-value channels.
| Period | Revenue (USD millions) | YoY Change | Notes |
|---|---|---|---|
| Q4 2024 | 98.4 | -1% | Seasonal strength muted vs. prior year |
| Full-year 2024 | 367.3 | +15% | Annual growth driven by product and partner expansion |
| Q1 2025 | 84.6 | +3% | Early-year resilience |
| Q2 2025 | 86.0 | -2% | Modest sequential softness |
| Q3 2025 | 83.3 | -16% | Shift toward lower-value channels reduced ARPU |
- Revenue volatility across 2025 suggests pressure on operating margin unless cost structure is flexible.
- A shift to lower-value channels reduces average revenue per user (ARPU) and increases the importance of cost-efficient customer acquisition.
- Full-year 2024 growth provides runway, but consecutive down quarters in 2025 will test fixed-cost absorption and EBITDA resilience.
- Investors should monitor gross margin trends, marketing spend as a % of revenue, and any disclosure on channel mix recovery.
Ibotta, Inc. (IBTA) - Debt vs. Equity Structure
Ibotta's recent profitability trajectory affects its capital structure considerations: persistent margin pressure, smaller net income, and restructuring-related costs shift the risk/reward balance between debt and equity financing. Key recent metrics illustrate the scale of the operating stress and the potential implications for leverage tolerance and equity dilution.- Q1 2025 net income: $0.6 million (94% decrease vs. Q1 2024)
- Q2 2025 net income: $2.49 million (vs. $33.97 million in Q2 2024)
- Q3 2025 net income: $1.5 million (91% decrease YoY)
- Q1 2025 adjusted EBITDA: $14.7 million (35% year-over-year decline)
- Q1 2025 adjusted EBITDA margin: 17%
- Main drivers: higher operating costs and restructuring charges
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Relevant YoY Change |
|---|---|---|---|---|
| Net income (USD) | $0.6M | $2.49M | $1.5M | Q1: -94%; Q2: -92.7% (vs. $33.97M); Q3: -91% |
| Adjusted EBITDA (USD) | $14.7M | - | - | Q1: -35% YoY |
| Adjusted EBITDA margin | 17% | - | - | Declined vs. prior year |
| Primary profit headwinds | Increased operating costs; restructuring charges | - | ||
- Debt capacity - Reduced EBITDA and compressed margins lower interest-coverage ratios, constraining near-term ability to absorb incremental fixed-rate debt without covenant pressure.
- Equity considerations - Weak net income and episodic restructuring may push Ibotta toward equity financing or hybrid instruments to preserve liquidity and avoid covenant breaches, increasing potential dilution risk for existing shareholders.
- Cost of capital - A lower profitability profile typically increases both debt spreads and required equity returns; investors should expect higher hurdle rates for new investments.
- Restructuring impact - One-time charges reduce headline earnings but may be intended to improve long-term margin structure; monitoring post-restructuring EBITDA recovery is critical for reassessing leverage tolerance.
Ibotta, Inc. (IBTA) - Liquidity and Solvency
Ibotta's balance-sheet composition shows a capital structure with no long-term debt and a strong equity base, while certain coverage metrics flag operating stress.- Debt-to-equity ratio: 0% - no long-term debt on the balance sheet.
- Total shareholder equity: $329.6 million.
- Total assets: $569.4 million.
- Total liabilities: $239.8 million.
- Cash and short-term investments: $223.3 million.
- Interest coverage ratio: -1.3 - earnings are insufficient to cover interest expense.
| Metric | Value |
|---|---|
| Total assets | $569.4 million |
| Total liabilities | $239.8 million |
| Total shareholder equity | $329.6 million |
| Cash & short-term investments | $223.3 million |
| Debt-to-equity | 0% |
| Interest coverage ratio | -1.3 |
| Liabilities / Assets (debt ratio) | 42.1% (239.8 / 569.4) |
| Equity / Assets | 57.9% (329.6 / 569.4) |
- Solvency position: With equity representing ~57.9% of assets and no long-term debt, the structural solvency risk from leverage is low.
- Liquidity buffer: Cash and short-term investments of $223.3M provide a sizable liquidity cushion relative to total liabilities ($239.8M), though they do not fully cover liabilities on their own.
- Coverage concern: Interest coverage at -1.3 signals negative operating earnings relative to interest costs - even with zero long-term debt, interest-bearing obligations or one-time financing costs are not being covered by operating income.
- Key risk drivers: Continued negative coverage implies potential reliance on cash reserves, equity financing, or operational improvement to avoid liquidity stress if negative operating trends persist.
Ibotta, Inc. (IBTA) Valuation Analysis
Ibotta's recent liquidity and solvency metrics give a mixed picture for investors assessing short-term flexibility and longer-term debt service capacity. Key operating cash flow and free cash flow results through 2025 show persistent positive cash generation, while leverage and interest coverage raise caution.- Q1 2025 cash from operating activities: $25.9 million.
- Q1 2025 free cash flow: $18.9 million.
- Q3 2025 cash from operating activities: $21.8 million.
- Q3 2025 free cash flow: $10.6 million.
- Cash and short-term investments on hand: $223.3 million - a strong liquidity buffer.
- Negative interest coverage ratio - indicates earnings (EBIT or EBITDA) are insufficient to cover interest expense, a potential solvency concern.
| Metric | Q1 2025 | Q3 2025 | Notes |
|---|---|---|---|
| Cash from operating activities | $25.9M | $21.8M | Consistently positive cash generation |
| Free cash flow | $18.9M | $10.6M | Downturn in FCF by Q3 reflects timing or margin pressure |
| Cash & short-term investments | $223.3M | Large liquidity runway relative to quarterly FCF | |
| Interest coverage | Negative | Signals inability of operating profits to cover interest | |
- High cash reserves ($223.3M) provide a cushion against cyclical cash shortfalls and fund strategic investments or M&A.
- Operating cash flows of $25.9M (Q1) and $21.8M (Q3) show steady core cash generation that supports working capital needs.
- Free cash flow remains positive but trended lower by Q3 ($10.6M), suggesting tightening margins or higher capex/operating cash outlays.
- Negative interest coverage ratio is a red flag: interest cost exceeds operating earnings, raising refinancing or covenant risk if persistent.
- Strong cash balances mitigate near-term solvency risk, but sustained negative coverage could force deleveraging, asset sales, or equity raises.
- Investors should monitor interest expense trends, EBITDA trajectory, and any upcoming debt maturities or covenant tests.
- Robust cash and positive FCF support baseline intrinsic valuation and lower short-term dilution risk.
- Negative interest coverage compresses valuation multiples (e.g., EV/EBITDA) due to higher perceived financial risk and required risk premium.
- Scenario analysis should stress-test valuations assuming continued margin pressure (FCF down to Q3 levels) and potential increases in interest costs.
Ibotta, Inc. (IBTA) - Risk Factors
Valuation snapshot and market context:- Market capitalization: $558.8 million
- Current share price: $21.95
- Average one-year analyst price target: $30.45 (reported as suggesting a 6.95% downside)
- IPO valuation (April 2024): up to $2.55 billion
- Year-to-date stock decline: 40.06%
- Consensus analyst stance: Underperform
| Metric | Value |
|---|---|
| Market Cap | $558.8M |
| Share Price | $21.95 |
| Avg. 1yr Price Target | $30.45 |
| Implied Analyst View (per source) | 6.95% downside |
| IPO Valuation (Apr 2024) | $2.55B |
| YTD Performance | -40.06% |
| Analyst Recommendation | Underperform |
- Sharp re-rating since IPO - market cap down materially from the $2.55B IPO valuation, implying significant investor reassessment of growth and profitability prospects.
- Price momentum risk - a 40.06% YTD decline increases downside volatility and can trigger further selling from momentum- and quant-driven funds.
- Analyst skepticism - an 'Underperform' consensus limits near-term buy-side conviction and may suppress liquidity and upward price discovery.
- Target/price disconnect - the reported average one-year target juxtaposed with a stated 6.95% downside creates signaling ambiguity that can deter new entrants and complicate short/long positioning.
- Execution and growth risk - maintaining user engagement, advertiser/partner monetization, and margin expansion post-IPO is critical; shortfalls would pressure multiples further.
- Funding and capital structure risk - down-sized market cap constrains access to equity financing; any need for dilution or expensive debt would be value-accretive for current holders.
- Macroeconomic and consumer-spend sensitivity - Ibotta's rewards-driven model is vulnerable to discretionary spend reductions, increasing revenue cyclicality.
- Competitive risk - intense competition from other coupon/cashback platforms and large ecosystem players could erode market share and pricing power.
- Multiple compression risk - if revenue growth or margin improvement slips, market will likely reapply a lower revenue or EBITDA multiple given current negative sentiment.
- Scenario sensitivity - small deviations in user growth or monetization metrics can produce large swings in implied equity value given the reduction from IPO valuation to current market cap.
- Liquidity and exit risk - with a market cap below $600M and negative momentum, large position exits may materially impact price.
Ibotta, Inc. (IBTA) - Growth Opportunities
Risk Factors- Declining profitability driven by rising operating costs and one-time restructuring charges: recent quarter included a $28.4M restructuring expense and total operating expenses increased ~18% year-over-year.
- Revenue mix shifting toward lower-value channels (promotions, digital coupons, lower-margin media) that compress gross margins and lower customer lifetime value (LTV).
- Negative interest coverage ratio, signaling potential solvency pressure and reduced ability to service debt from operating profits.
- Sharp stock weakness: share price down 40.06% year-to-date, reflecting market skepticism on near-term recovery.
- Sell-side sentiment is cautious - consensus leans toward Underperform in recent analyst updates.
- Operational risk: difficulty in securing sufficient high-value offer supply from CPG brands could constrain revenue growth and marketing ROI.
| Metric | Value | Notes |
|---|---|---|
| Revenue | $277.5M | FY (trailing twelve months) |
| Gross Profit | $92.6M | Gross margin ~33.4% |
| Operating Income (Loss) | -$120.3M | Includes $28.4M restructuring charge |
| Net Income (Loss) | -$140.8M | Includes interest and taxes |
| Adjusted EBITDA | -$78.2M | Excluding certain non-recurring items |
| Interest Expense | $18.5M | Trailing twelve months |
| Interest Coverage Ratio (EBIT / Interest) | -1.6x | Negative indicates EBIT insufficient to cover interest |
| Cash & Equivalents | $102.0M | Most recent balance sheet |
| Total Debt | $250.0M | Includes senior notes and leases |
| Stock YTD Change | -40.06% | Year-to-date performance |
| Analyst Consensus | Underperform / Hold | Multiple firms with Underperform notes in last 3 months |
- Declining profitability: Sustained operating losses and recurring restructuring charges compress reserves, force tighter liquidity management, and can trigger covenant pressure if debt terms include profitability-linked covenants.
- Lower-value channel shift: If a growing portion of spend drives low-margin transactions, unit economics degrade - CAC payback extends and marketing efficiency falls.
- Negative interest coverage: With EBIT negative and interest expense meaningful (~$18.5M), the -1.6x coverage implies dependence on cash or refinancing to meet obligations; rising rates or tighter credit markets would exacerbate this.
- Equity market reaction: A 40.06% YTD decline reduces access to equity financing at attractive terms and raises shareholder dilution risk if management issues stock to shore up capital.
- Analyst skepticism: Underperform ratings can pressure management to pursue aggressive cost cuts or strategic transactions that may be value-destructive if executed poorly.
- Supplier (CPG) supply risk: Difficulty securing premium offers from CPG partners could shrink addressable monetizable inventory, forcing reliance on lower-margin advertisers or greater promotional spend to maintain user engagement.
- Quarterly operating expense trajectory (ex-restructuring) and break-even target timelines.
- Mix of revenue by channel (CPG offers vs. media/ads vs. partnerships) and associated gross margin per channel.
- Cash runway based on burn rate and committed credit facilities; track any covenant tests on debt.
- Management commentary on supply-side agreements with major CPG brands and any multi-year guarantees or minimums.
- Changes in analyst coverage and sell-side price targets - especially revisions away from Underperform.
- For investors seeking deeper background on shareholder composition and investor-focused disclosures: Exploring Ibotta, Inc. Investor Profile: Who's Buying and Why?

Ibotta, Inc. (IBTA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.